KACI MUNDHENKE: Open Payments
NPI 1730834102 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,308 in 54 payments from 19 companies in 2025. Trend: 2023 $918 · 2024 $788 · 2025 $1,308
Food & beverage: $1,308
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 3 | $178 |
| Novo Nordisk Inc | 8 | $176 |
| Lilly USA, LLC | 10 | $151 |
| PFIZER INC. | 6 | $120 |
| Dexcom, Inc. | 3 | $118 |
| Otsuka America Pharmaceutical, Inc. | 3 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Exact Sciences Corporation | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
Products named: TZIELD, MOUNJARO, Dexcom G6 Transmitter, REXULTI, Kerendia, NURTEC ODT, XIFAXAN, Wegovy.
Industry payments across SC — which companies pay providers there.
